Skip to main content
logo
GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.880
+0.590 (25.76%)
At close: Sep 4, 2026, 4:00 PM EDT
2.584
-0.296 (-10.28%)
After-hours: Sep 4, 2026, 7:59 PM EDT

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6272--
Market Cap Growth
71.44%-66.25%326.73%---
Enterprise Value
-5-13-2--
Last Close Price
2.886.91394.3216674.51--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.610.421.846.70--
P/TBV Ratio
0.610.421.846.70--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.030.05-0.41-0.74
Net Debt / Equity Ratio
-1.06-1.36-1.22-6.93-0.41-0.73
Net Debt / EBITDA Ratio
1.130.680.600.16-0.30-3.33
Net Debt / FCF Ratio
1.050.800.570.20-0.61-4.16
Quick Ratio
9.953.113.070.670.010.02
Current Ratio
10.303.253.431.090.160.02
Return on Equity (ROE)
-142.02%-238.17%-382.52%---
Return on Assets (ROA)
-70.93%-103.93%-118.39%-416.93%-465.68%-226.54%
Return on Capital Employed (ROCE)
-94.10%-198.90%-200.70%-4300.00%139.00%22.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-153.41%-478.65%-110.90%-751.78%--
FCF Yield
-165.47%-407.91%-116.36%-518.87%--
SEC Filings: 10-K · 10-Q